Business Daily from THE HINDU group of publications
Wednesday, Jan 30, 2008
ePaper | Mobile/PDA Version
Business Daily from THE HINDU group of publications Wednesday, Jan 30, 2008 ePaper | Mobile/PDA Version |
|
|
|
|
|
|
|
Corporate
-
Research & Development States - Andhra Pradesh
To jointly work on drug molecules. The tie-up will focus on aging and cardio disorders. Our Bureau Hyderabad, Jan. 29 Hyderabad-based Institute of Life Sciences (ILS) has inked a memorandum of understanding with the US-based Wistar Institute of Anatomy and Biology to collaborate in discovery research. The ILS and Wistar Institute will jointly work to discover small molecule drug candidates for obesity and diabetes, Dr Javed Iqbal, Director, ILS, told newspersons here on Tuesday, on the sidelines of a one-day symposium on chemical biology organised to mark the first anniversary of ILS. In addition to the drugs for treating obesity and diabetes, the institute, set up in public-private participation mode by Dr Reddy’s Laboratories and Research Foundation, Andhra Pradesh Government and the University of Hyderabad, is also working on anti-aging candidates. “We will work together for discovery and development of compounds targeting proteins known as Sirtuins (known to address problems associated with aging, diabetes and cardio-vascular disorders),” he said. Wistar will provide ILS with information about the chemical structure of sirtuin modulators identified by its in-house research. The ILS would carry out medicinal chemistry to prepare analogues of these modulators to be provided to Wistar for biological testing. More Stories on : Research & Development | Pharmaceuticals | Dr. Reddy's Laboratories Ltd | Andhra Pradesh
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2008, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|